Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Book chapter
-
Reference no. 6607BC
Published by: Harvard Business Publishing
Published in: 2008

Abstract

What types of firms compete in the biotechnology segment? How have these changed over time? What kind of strategies have they pursued? And what capabilities do they have? This chapter describes the emergence of biotechnology as a new segment of the pharmaceutical industry, analyzing how firm capabilities, technological strategies, and business models have evolved over time.

About

Abstract

What types of firms compete in the biotechnology segment? How have these changed over time? What kind of strategies have they pursued? And what capabilities do they have? This chapter describes the emergence of biotechnology as a new segment of the pharmaceutical industry, analyzing how firm capabilities, technological strategies, and business models have evolved over time.

Settings


Related